Genotyping of Plasmodium falciparum using antigenic polymorphic markers and to study anti-malarial drug resistance markers in malaria endemic areas of Bangladesh

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Akter, Jasmin ^a   Thriemer, Kamala ^b   Khan, Wasif A ^a   Sullivan, David J ^c   Noedl, Harald ^b   Haque, Rashidul ^a  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Anti malarial drug resistance markers; Genotype; Malaria; MSP 1 and pfcrt; Plasmodium falciparum

Indexed keywords

ANTIGEN; ARTEMISININ; CHLOROQUINE; FOLIC ACID ANTAGONIST;

ALLELE; ARTICLE; BANGLADESH; DISEASE MARKER; DNA EXTRACTION; ENDEMIC DISEASE; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HUMAN; MALARIA; MALARIA FALCIPARUM; MUTATION; PARASITE; PLASMODIUM FALCIPARUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, PROTOZOAN; ANTIMALARIALS; BANGLADESH; DRUG RESISTANCE; ENDEMIC DISEASES; GENETIC VARIATION; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84869881954     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-386     Document Type: Article

References (18)

1. World Health Organization, 2005 http://rbm.who.int/wmr2005/profiles/ bangladesh.pdf
2. Prevalence of the K76T mutation in the putative Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene and its relation to chloroquine resistance in Mozambique. Mayor AG, Gomez-Olive X, Aponte JJ, Casimiro S, Mabunda S, Dgedge M, Barreto A, Alonso PL, J Infect Dis 2001 183 1413 1416 10.1086/319856 11294676
3. Impact of chloroquine resistance on malaria mortality. Trape JF, Pison G, Preziosi MP, Enel C, Desgrees du Lou A, Delaunay V, Samb B, Lagarde E, Molez JF, Simondon F, C R Acad Sci 1998 321 689 697 10.1016/S0764-4469(98)80009-7
4. Drug resistance in Plasmodium falciparum from the Chittagong Hill Tracts. Bangladesh. van den Broek IV, van der Wardt S, Talukder L, Chakma S, Brockman A, Nair S, Anderson TC, Trop Med Int Health 2004 9 680 687 10.1111/j.1365-3156. 2004.01249.x 15189458
5. Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. Brockman A, Paul RE, Anderson TJ, Hackford I, Phaiphun L, Looareesuwan S, Nosten F, Day KP, AmJTrop Med Hyg 1999 60 14 21
6. Methodological issues in the assessment of antimalarial drug treatment: analysis of 13 studies in eight African countries from 2001 to 2004. Guthmann JP, Pinoges L, Checchi F, Cousens S, Balkan S, van Herp M, Legros D, Olliaro P, Antimicrob Agents Chemother 2006 50 11 3734 3739 10.1128/AAC.01618-05 16954313
7. Impact of transmission intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trials. Greenhouse B, Dokomajilar C, Hubbard A, Rosenthal PJ, Dorsey G, Antimicrob Agents Chemother 2007 51 3096 3103 10.1128/AAC.00159-07 17591848
8. The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment. Snounou G, Beck HP, Parasitol Today 1998 14 462 467 10.1016/S0169-4758(98)01340-4 17040849
9. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh. Haque R, Thriemer K, Wang Z, Sato K, Wagatsuma Y, Salam MA, Akther S, Akter J, Fukuda M, Miller RS, Noedl H, AmJTrop Med Hyg 2007 76 39 41
10. Azithromycin combination therapy for the treatment of uncomplicated falciparum malaria in Bangladesh: an open-label randomized, controlled clinical trial. Thriemer K, Starzengruber P, Khan WA, Haque R, Marma AS, Ley B, Vossen MG, Swoboda P, Akter J, Noedl H, J Infect Dis 2010 202 392 398 10.1086/653710 20557237
11. Therapeutic efficacy of quinine plus sulfadoxine-pyremethamine for the treatment of uncomplicated falciparum malaria in Bangladesh. Thriemer K, Haque R, Wagatsuma Y, Salam MA, Akther S, Attlmayr B, Fukuda M, Schaecher K, Miller RS, Noedl H, AmJTrop Med Hyg 2006 75 645 649
12. Rapid diagnostic tests for malaria parasites. Moody A, Clin Microbiol Rev 2002 15 1 66 78 10.1128/CMR.15.1.66-78.2002 11781267
13. Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. Farnert A, Arez AP, Babiker HA, Beck HP, Benito A, Bjorkman A, Bruce MC, Conway DJ, Day KP, Henning L, Trans R Soc Trop Med Hyg 2001 95 225 232 10.1016/S0035-9203(01)90175-0 11355566
14. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Snounou G, Zhu X, Siripoon N, Jarra W, Thaithong S, Brown KN, Viriyakosol S, Trans R Soc Trop Med Hyg 1999 93 369 374 10.1016/S0035-9203(99)90120-7 10674079
15. A molecular marker for chloroquine-resistant falciparum malaria. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock DA, N Engl J Med 2001 344 257 263 10.1056/NEJM200101253440403 11172152
16. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC, Mol Biochem Parasitol 2000 108 13 23 10.1016/S0166-6851(00)00201-2 10802315
17. Dynamics of pfcrt alleles CVMNK and CVIET in chloroquine-treated Sudanese patients infected with Plasmodium falciparum. Gadalla NB, Elzaki SE, Mukhtar E, Warhurst DC, El-Sayed B, Sutherland CJ, Malar J 2010 9 74 10.1186/1475-2875-9- 74 20226032
18. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Pickard AL, Wongsrichanalai C, Purfield A, Kamwendo D, Emery K, Zalewski C, Kawamoto F, Miller RS, Meshnick SR, Antimicrob Agents Chemother 2003 47 2418 2423 10.1128/AAC.47.8.2418-2423.2003 12878499